Split History
ETFs Holding BSTC »    BSTC Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Biospecifics Technologies is a biopharmaceutical company involved in the development of an injectable collagenase clostridium histolyticum (CCH). Co. maintains intellectual property with respect to injectable CCH that treats, among other indications, Dupuytren's contracture (DC), Peyronie's disease (PD), frozen shoulder syndrome, and uterine fibroids. Injectable CCH is approved and marketed under the trademark XIAFLEX® for the treatment of both DC and PD. Co. is evaluating CCH as a treatment for uterine fibroids. Under its license agreement with Endo International plc's (Endo), Endo has the right to develop CCH for frozen shoulder and plantar fibromatosis, and other licensed indications. According to our BSTC split history records, Biospecifics Tech has had 1 split.
BSTC split history picture
Biospecifics Tech (BSTC) has 1 split in our BSTC split history database. The split for BSTC took place on April 21, 1992. This was a 2 for 1 split, meaning for each share of BSTC owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split.

When a company such as Biospecifics Tech splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.

Looking at the BSTC split history from start to finish, an original position size of 1000 shares would have turned into 2000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Biospecifics Tech shares, starting with a $10,000 purchase of BSTC, presented on a split-history-adjusted basis factoring in the complete BSTC split history. BSTC split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 06/28/2012
End date: 12/02/2020
Start price/share: $18.46
End price/share: $88.53
Dividends collected/share: $0.00
Total return: 379.58%
Average Annual Total Return: 20.42%
Starting investment: $10,000.00
Ending investment: $47,944.92
Years: 8.44
Date Ratio
04/21/19922 for 1
BSTC is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

BSX Split History
BTI Split History
BTX Split History
CAH Split History
CALA Split History
CAPR Split History
CASC Split History
CASI Split History
CATB Split History
CBIO Split History

Also explore: BSTC shares outstanding history

Email EnvelopeFree BSTC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

South Star Battery Metals Corp. (STS.CA)
Calithera Biosciences, Inc. (CALA)
TDH Holdings, Inc. (PETZ)
Fortinet (FTNT)
AIkido Pharma, Inc. (AIKI)
Histogen Inc. (HSTO)
Farmmi, Inc. (FAMI)
CASI Pharmaceuticals, Inc. (CASI)
Blue Hat Interactive Entertainment Technology (BHAT)
Baosheng Media Group Holdings Limited (BAOS)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

BSTC Insider Buying

BSTC Split History | www.SplitHistory.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.